Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02046902 · ClinicalTrials.gov registry record
Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
A clinical trial of Heart Diseases, sponsored by University of Missouri, Kansas City.
- Completed
- Registry status
- 586
- Enrollment target
- 2
- Study locations
NCT02046902: Completed study of Heart Diseases, sponsored by University of Missouri, Kansas City.
NCT02046902 is a study of Heart Diseases that has completed, run by University of Missouri, Kansas City. The registered enrollment target is 586 participants, below the 5,525-participant average among 85 other Heart Diseases trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02046902, a study of Heart Diseases, has completed, sponsored by University of Missouri, Kansas City.
- COMPLETED
- Registry status
- 586 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this study is to gather input from patients who have undergone PCI, their family and/or caregivers, and clinicians to develop a patient decision aid. The purpose of the decision aid is to deliver information, including individualized estimates of patients' restenosis risk, in an understandable format that would be informative and assist in decision-making for patients undergoing PCI.
Primary Outcome
The primary outcome was whether or not patients participated in SDM regarding stent choice. Patients were categorized as having participated in SDM if they answered anything other than "doctor alone" in response to the question "Who chose the type of stent?"
Conditions Studied
Study Locations (2)
Missouri
- Truman Medical Center - Kansas City
- Saint Luke's Hospital of Kansas City - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 586 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-12-31 |
What the finished NCT02046902 record still lists
NCT02046902 is an observational study that tracks outcomes without assigning an intervention. The registered 586 participants enrollment target is mid-sized for trials with a published cap, below the 5,525-participant average among 85 other Heart Diseases trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Heart Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT02046902 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT02046902 about?
NCT02046902 is a clinical study titled "Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection". The goal of this study is to gather input from patients who have undergone PCI, their family and/or caregivers, and clinicians to develop a patient decision aid. The purpose of the decision aid is to deliver information, including individualized estimates of patients' restenosis risk, in an understa...
What is the current status of trial NCT02046902?
This trial is currently completed. The enrollment target is 586 participants. The study started on 2014-09. Estimated completion is 2016-12-31.
What conditions does trial NCT02046902 study?
This clinical trial studies the following conditions: Heart Diseases.
Who is sponsoring clinical trial NCT02046902?
This trial is sponsored by University of Missouri, Kansas City, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02046902 being conducted?
This trial has 2 study locations across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02046902's enrollment target sits among peer trials
586 37th of 85 higher than 49 of 85 other Heart Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Angiography and Electrogram Guided Bachmann Bundle Pacing
RECRUITING · NA
-
Understanding Decentralized Trial Engagement and Clinical Impediments Through Digital Efforts (UDECIDE) Among Unrepresented Groups With Poor Cardiovascular and Cardiometabolic Health
RECRUITING · NA
-
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
RECRUITING · NA
-
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR
RECRUITING · NA
-
Lumason® Infusion vs. Bolus Administrations
RECRUITING · Phase 3
-
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04134260 · 586 participants · Phase 3
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial
- NCT06100770 · 586 participants
Aveir AR Coverage With Evidence Development (CED) Study
- NCT06183281 · 586 participants · NA
Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity
- NCT06976203 · 586 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia